Researchers at the Kennedy Institute of Rheumatology have found that physically resisting the formation of an immunological synapse actually promotes a stronger immune response. The findings could ...

New UAB research uncovers how NFAT helps uterine NK cells support early placenta development, shedding light on pregnancy health and the roots of complications like preeclampsia.

A recent review identifies interleukin-36 (IL-36) as a transformative driver of vascular inflammation, revealing that serum ...

Researchers at the University of California San Diego and collaborators have discovered a new way to help the immune system fight ovarian cancer by changing how tumors ...

Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

Atherosclerosis represents a chronic inflammatory disease characterized by the accumulation of lipid-laden macrophage foam cells within arterial ...

Rather than aligning with classical hematopoietic signaling, the peptide has been theorized to engage selective molecular pathways associated with cellular stress response, immunomodulatory signaling, ...

Cornell researchers have uncovered a built-in molecular "gate" that controls the production of the molecule nitric oxide, a crucial signaling molecule throughout biology that in humans helps regulate ...

When researchers tested it in cell samples taken from multiple cancer types, including head and neck, lung, and melanoma, they found that it stopped the cancer cells from dividing and replicating, ...

Perovskite solar cells have long been the most exciting “almost there” technology in clean energy. In laboratories, they already rival the best silicon solar cells, converting more than 26 percent of ...

A research team from Osaka Metropolitan University have developed a donor-acceptor-donor molecule that can spontaneously self-assemble into nanoscale structures and offer a more stable route to ...

Erythropoietin (EPO) signaling triggers immune tolerance by activating regulatory T-cells. Blocking EPO signaling converts certain cells into powerful activators of immune response. Targeting this ...